STATE STREET CORP

Position in CDIO — Cardio Diagnostics Holdings, Inc.

CIK 93751 BOSTON, MA

Position in CDIO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$22,116

+$1,459 QoQ

Shares Held

10,099

+383.9% QoQ

Ownership

0.341%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,549,056,533 across 410 Biotechnology names. CDIO ranks #395 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,871,459	$5,896,909,829
2	REGN	Regeneron Pharmaceuticals, Inc.	4,834,688	$3,014,621,355
3	INCY	Incyte Corp	9,722,336	$1,102,124,008
4	MRNA	Moderna, Inc.	15,726,193	$1,101,305,295
5	ALNY	Alnylam Pharmaceuticals, Inc.	3,555,689	$1,070,369,059
6	RVMD	Revolution Medicines, Inc.	4,897,051	$917,119,711
7	RPRX	Royalty Pharma plc	12,338,229	$691,804,500
8	INSM	INSMED Inc	6,052,174	$645,282,791

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,116	10,099	-83.9%	Shares	Defined	2026-08-07
2025-03-31	$20,657	62,600	0.0%	Shares	Defined	2025-05-15
2024-12-31	$57,404	62,600	+43.9%	Shares	Defined	2025-02-14
2024-09-30	$9,700	43,500	0.0%	Shares	Defined	2024-11-14
2024-06-30	$23,924	43,500	0.0%	Shares	Defined	2024-08-14
2024-03-31	$61,769	43,500	+116.4%	Shares	Defined	2024-05-15
2023-12-31	$50,048	20,100	0.0%	Shares	Defined	2024-02-14
2023-09-30	$6,833	20,100	0.0%	Shares	Defined	2023-11-14
2023-06-30	$23,918	20,100	-51.8%	Shares	Defined	2023-08-14
2023-03-31	$163,046	41,700	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.